Suwanee, GA – Tekton Research is pleased to announce their strategic partnership with esteemed Dr. Ravi Singareddy, M.D., specializing in psychiatry and sleep medicine. With over 25 years of medical experience, Dr. Singareddy brings a wealth of expertise and a patient-centered approach to advancing clinical research in these critical fields.
Dr. Singareddy is board-certified in psychiatry and sleep medicine. He earned his medical degree from Kurnool Medical College in 1995 and completed a combined residency in internal medicine and psychiatry at Wayne State University, followed by a fellowship in sleep medicine and anxiety disorders. Before transitioning into private practice, he spent nearly a decade at Penn State University Medical Center, where he was actively involved in training residents, conducting research, and treating patients. His research has been published in leading medical journals, with a focus on anxiety disorders, depression, and sleep disorders.
Currently, Dr. Singareddy leads Empower Psychiatry and Sleep in Suwanee, Georgia. His care philosophy emphasizes improving overall well-being through the comprehensive evaluation and treatment of emotional disorders and sleep disturbances, while considering both individual preferences and evidence-based medicine. He offers specialized treatments such as Spravato (EsKetamine), Transcranial Magnetic Stimulation (TMS), and Suboxone therapy. He is also an active member of the American Psychiatric Association and the American Academy of Sleep Medicine.
“Joining Tekton Research is an exciting opportunity to contribute to groundbreaking studies in psychiatry and sleep medicine,” said Dr. Singareddy. “Mental health and sleep disorders have a profound impact on quality of life, and through clinical research, we can help shape the future of patient care by bringing new treatment options to those in need.”
Tekton Research leaders expressed enthusiasm about Dr. Singareddy’s addition to the team. “Dr. Singareddy’s extensive experience and dedication to patient care will be invaluable as we continue to advance clinical research in psychiatry and sleep medicine,” said Jeffrey Zucker, Chief Expansion Officer at Tekton Research. “His expertise aligns with our mission to improve treatment options and enhance patient outcomes through high-quality clinical trials.”
Dr. Singareddy’s partnership with Tekton Research marks another step forward in the organization’s continued growth and commitment to advancing clinical research. By expanding their network of experienced investigators, Tekton is able to further its mission of Making Life Better, remaining dedicated to the improvement of patient health.
